These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38885755)

  • 21. Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease.
    Gao P; Zhang J; He X; Hao Y; Wang K; Gibson PG
    PLoS One; 2013; 8(5):e57678. PubMed ID: 23741289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin, C-reactive protein, PaCO2, and noninvasive mechanical ventilation failure in chronic obstructive pulmonary disease exacerbation.
    Wang J; Shang H; Yang X; Guo S; Cui Z
    Medicine (Baltimore); 2019 Apr; 98(17):e15171. PubMed ID: 31027061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between decrease of CRP and resolution of airway inflammatory response, improvement of health status, and clinical outcomes during severe acute exacerbation of chronic obstructive pulmonary disease.
    Liang Y; Chang C; Zhu H; Shen N; He B; Yao W
    Intern Emerg Med; 2015 Sep; 10(6):685-91. PubMed ID: 25822151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
    Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
    Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
    Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expressions and significance of APN, D-D, IL-17 and hs-CRP in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Ding GZ; Li WS
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6463-6468. PubMed ID: 30338815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure.
    Yao C; Wang L; Shi F; Chen R; Li B; Liu W; Feng M; Li S
    Int J Med Sci; 2021; 18(7):1592-1599. PubMed ID: 33746575
    [No Abstract]   [Full Text] [Related]  

  • 28. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations: A protocol for systematic review and meta-analysis.
    An X; Zhang C; Weng X; Xiao W; Sun Z; Zeng Z; Huang Q
    Medicine (Baltimore); 2020 Jul; 99(29):e21152. PubMed ID: 32702869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of High-Dose Vitamin D Replacement on the Serum Levels of Systemic Inflammatory Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Dastan F; Salamzadeh J; Pourrashid MH; Edalatifard M; Eslaminejad A
    COPD; 2019 Aug; 16(3-4):278-283. PubMed ID: 31550915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
    Mohamed Amine M; Selma M; Adel S; Khaoula BHA; Mohamed Hassene K; Imen T; Ahmed A; Nadia BB; Yosra BD; Rabie R; Mohamed Habib G; Kaouthar B; Mehdi M; Asma B; Wahid B; Riadh B; Hamdi B; Semir N;
    PLoS One; 2021; 16(5):e0251716. PubMed ID: 34015041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum C-reactive protein level and distribution in chronic obstructive pulmonary disease versus healthy controls: a case-control study from Iran.
    Firouzjahi A; Monadi M; Karimpoor F; Heidari B; Dankoob Y; Hajian-Tilaki K; Firozjaii MG
    Inflammation; 2013 Oct; 36(5):1122-8. PubMed ID: 23624662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-coverage lipidomics analysis reveals biomarkers for diagnosis of acute exacerbation of chronic obstructive pulmonary disease.
    Liu X; Zhang H; Si Y; Du Y; Wu J; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jun; 1201-1202():123278. PubMed ID: 35561641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations.
    Chen YR; Chen V; Hollander Z; Leipsic JA; Hague CJ; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    PLoS One; 2017; 12(3):e0174063. PubMed ID: 28328968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
    Yao C; Liu X; Tang Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased CD34+ cell number is correlated with cardiac dysfunction in patients with acute exacerbation of COPD.
    Liu Y; Liu X; Lin G; Sun L; Li H; Xie C
    Heart Lung Circ; 2014 Sep; 23(9):875-82. PubMed ID: 24875532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
    Moretti M; Fagnani S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Evaluation of Serum Pentraxin-3 and High-Sensitivity C-Reactive Protein Levels in Patients with Acute Attack of COPD.
    Duran L; Unsal M; Yardan T; Kati C; Bedir A; Turkeli S; Ekiz M
    Clin Lab; 2015; 61(12):1911-6. PubMed ID: 26882815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the significance of circulating insulin-like growth factor-1 and C-reactive protein in patients with chronic obstructive pulmonary disease.
    Ye M; Yu H; Yu W; Zhang G; Xiao L; Zheng X; Wu J
    J Int Med Res; 2012; 40(3):1025-35. PubMed ID: 22906275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.